LOCUS       AAB07223                3418 aa            linear   PRI 03-SEP-1996
DEFINITION  BRCA2 [Homo sapiens].
ACCESSION   AAB07223
VERSION     AAB07223.1
DBSOURCE    locus HSU43746 accession U43746.1
KEYWORDS    .
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (sites)
  AUTHORS   Teng,D.H., Bogden,R., Mitchell,J., Baumgard,M., Bell,R., Berry,S.,
            Davis,T., Ha,P.C., Kehrer,R., Jammulapati,S., Chen,Q., Offit,K.,
            Skolnick,M.H., Tavtigian,S.V., Jhanwar,S., Swedlund,B., Wong,A.K.
            and Kamb,A.
  TITLE     Low incidence of BRCA2 mutations in breast carcinoma and other
            cancers
  JOURNAL   Nat. Genet. 13 (2), 241-244 (1996)
   PUBMED   8640236
REFERENCE   2  (residues 1 to 3418)
  AUTHORS   Tavtigian,S.V., Rommens,J.M., Couch,F.J., Neuhausen,S., Bell,R.,
            Berry,S., Bogden,R., Chen,Q., Davis,T., Frye,C., Hattier,T.,
            Jammulapati,S., Janecki,T., Jiang,P., Kehrer,R., Schroeder,M.,
            Snyder,S., Stringfellow,M., Stroup,C., Swedlund,B., Teng,D.,
            Thomas,A., Tran,T., Weaver-Feldhaus,J., Wong,A., Leblanc,J.-F.,
            Belanger,C., Tranchant,M., Samson,C., Dumont,M.,
            McArthur-Morrison,J., McSweeney,D., Peng,Y., Shizuya,H., Slepak,T.,
            Simon,M.I., Labrie,F., Shattuck-Eidens,D., Skolnick,M., Goldgar,D.,
            Weber,B.L., Simard,J. and Kamb,A.
  TITLE     Direct Submission
  JOURNAL   Submitted (21-DEC-1995) Sean Tavtigian, Myriad Genetics Inc.,
            Department of Research, 390 Wakara Way, Salt Lake City, 84106, USA
COMMENT     On Jan 19, 1996 this sequence version replaced gi:1131427.
            Tavtigian,S.V., Bell,R., Berry,S., Bogden,R., Chen,Q., Davis,T.,
            Frye,C., Hattier,T., Jammulapati,S., Janecki,T., Jiang,P.,
            Kehrer,R., Schroeder,M., Snyder,S., Stringfellow,M., Stroup,C.,
            Swedlund,B., Shattuck-Eidens,D., Skolnick,M., and  Kamb,A.
              Myriad Genetics Inc.
              390 Wakara Way
              Salt lake City, Utah 84106
            Rommens,J.M., McArthur-Morrison,J., and  McSweeney,D.
              Department of Genetics, Research Institute
              The Hospital for Sick Children
              Toronto, Canada
            Couch,F.J., Peng,Y. and Weber,B.L.
              Division of Hematology and Oncology
              Department of Medicine
              University of Pennsylvania Medical School
            Shizuya,H., Slepak,T., and  Simon,M.I.
              Division of Biology 157-75
              California Institute of Technology
            Dumont,M., Leblanc,J.-F., Belanger,C., Tranchant,M., Samson,C,.
            Labrie,F., and Simard,J.
              CHUL Research Center and Laval University
              Department of Molecular Endocrinology
              Quebec, Canada
            Neuhausen,S. and Goldgar,D.
              Department of Medical Informatics
              University of Utah Medical Center.
FEATURES             Location/Qualifiers
     source          1..3418
                     /organism="Homo sapiens"
                     /db_xref="taxon:9606"
                     /chromosome="13"
                     /map="13q12-q13"
     Protein         1..3418
                     /product="BRCA2"
     Region          1003..1034
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:279028"
     Region          1213..1244
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:279028"
     Region          1422..1453
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:279028"
     Region          1518..1549
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:279028"
     Region          1665..1696
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:279028"
     Region          1838..1869
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:279028"
     Region          1973..2003
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:279028"
     Region          2052..2082
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:279028"
     Region          2481..2667
                     /region_name="BRCA-2_helical"
                     /note="BRCA2, helical; pfam09169"
                     /db_xref="CDD:286278"
     Region          2670..2793
                     /region_name="BRCA-2_OB1"
                     /note="BRCA2, oligonucleotide/oligosaccharide-binding,
                     domain 1; pfam09103"
                     /db_xref="CDD:286226"
     Site            order(2690..2692,2718..2721,2723,2729..2731,2733,2749,
                     2757..2759,2775..2777)
                     /site_type="other"
                     /note="generic binding surface I"
                     /db_xref="CDD:239939"
     Site            order(2725,2736,2739,2744,2747,2750,2782..2785,2787..2788,
                     2791..2792)
                     /site_type="binding"
                     /note="binding surface II"
                     /db_xref="CDD:239939"
     Region          2804..3054
                     /region_name="BRCA2DBD_OB2"
                     /note="BRCA2DBD_OB2: A subfamily of OB folds corresponding
                     to the second OB fold (OB2) of the 800-amino acid
                     C-terminal ssDNA binding domain (DBD) of BRCA2 (breast
                     cancer susceptibility gene 2) protein, called BRCA2DBD.
                     BRCA2 participates in homologous...; cd04494"
                     /db_xref="CDD:239940"
     Site            order(2808..2809,2811..2814,2816)
                     /site_type="binding"
                     /note="binding surface II"
                     /db_xref="CDD:239940"
     Site            order(2826..2827,2829,2841,2846,2973,3050,3052..3054)
                     /site_type="other"
                     /note="OB2/OB3 interface [polypeptide binding]"
                     /db_xref="CDD:239940"
     Site            order(2841,2971,2988,2990..2991,3026,3028)
                     /site_type="other"
                     /note="ssDNA binding site [nucleotide binding]"
                     /db_xref="CDD:239940"
     Region          3057..3186
                     /region_name="BRCA-2_OB3"
                     /note="BRCA2, oligonucleotide/oligosaccharide-binding,
                     domain 3; pfam09104"
                     /db_xref="CDD:286227"
     Site            order(3073,3119,3121,3123,3147)
                     /site_type="other"
                     /note="generic binding surface II"
                     /db_xref="CDD:239941"
     Site            order(3086..3088,3128,3139,3141..3142)
                     /site_type="other"
                     /note="ssDNA binding site [nucleotide binding]"
                     /db_xref="CDD:239941"
     CDS             1..3418
                     /gene="BRCA2"
                     /coded_by="U43746.1:229..10485"
ORIGIN      
        1 mpigskerpt ffeifktrcn kadlgpisln wfeelsseap pynsepaees ehknnnyepn
       61 lfktpqrkps ynqlastpii fkeqgltlpl yqspvkeldk fkldlgrnvp nsrhkslrtv
      121 ktkmdqaddv scpllnscls espvvlqcth vtpqrdksvv cgslfhtpkf vkgrqtpkhi
      181 seslgaevdp dmswssslat pptlsstvli vrneeasetv fphdttanvk syfsnhdesl
      241 kkndrfiasv tdsentnqre aashgfgkts gnsfkvnsck dhigksmpnv ledevyetvv
      301 dtseedsfsl cfskcrtknl qkvrtsktrk kifheanade ceksknqvke kysfvsevep
      361 ndtdpldsnv ahqkpfesgs dkiskevvps lacewsqltl sglngaqmek ipllhisscd
      421 qnisekdlld tenkrkkdfl tsenslpris slpksekpln eetvvnkrde eqhleshtdc
      481 ilavkqaisg tspvassfqg ikksifrire spketfnasf sghmtdpnfk keteasesgl
      541 eihtvcsqke dslcpnlidn gswpatttqn svalknagli stlkkktnkf iyaihdetfy
      601 kgkkipkdqk selincsaqf eanafeaplt fanadsgllh ssvkrscsqn dseeptlslt
      661 ssfgtilrkc srnetcsnnt visqdldyke akcnkeklql fitpeadsls clqegqcend
      721 pkskkvsdik eevlaaachp vqhskveysd tdfqsqksll ydhenastli ltptskdvls
      781 nlvmisrgke sykmsdklkg nnyesdvelt knipmeknqd vcalnenykn vellppekym
      841 rvaspsrkvq fnqntnlrvi qknqeettsi skitvnpdse elfsdnennf vfqvanernn
      901 lalgntkelh etdltcvnep ifknstmvly gdtgdkqatq vsikkdlvyv laeenknsvk
      961 qhikmtlgqd lksdislnid kipeknndym nkwagllgpi snhsfggsfr tasnkeikls
     1021 ehnikkskmf fkdieeqypt slacveivnt laldnqkkls kpqsintvsa hlqssvvvsd
     1081 cknshitpqm lfskqdfnsn hnltpsqkae itelstilee sgsqfeftqf rkpsyilqks
     1141 tfevpenqmt ilkttseecr dadlhvimna psigqvdssk qfegtveikr kfagllkndc
     1201 nksasgyltd enevgfrgfy sahgtklnvs tealqkavkl fsdienisee tsaevhpisl
     1261 ssskchdsvv smfkienhnd ktvseknnkc qlilqnniem ttgtfveeit enykrntene
     1321 dnkytaasrn shnlefdgsd sskndtvcih kdetdllftd qhniclklsg qfmkegntqi
     1381 kedlsdltfl evakaqeach gntsnkeqlt atkteqnikd fetsdtffqt asgknisvak
     1441 esfnkivnff dqkpeelhnf slnselhsdi rknkmdilsy eetdivkhki lkesvpvgtg
     1501 nqlvtfqgqp erdekikept llgfhtasgk kvkiakesld kvknlfdeke qgtseitsfs
     1561 hqwaktlkyr eackdlelac etieitaapk ckemqnslnn dknlvsietv vppkllsdnl
     1621 crqtenlkts ksiflkvkvh enveketaks patcytnqsp ysviensala fytscsrkts
     1681 vsqtslleak kwlregifdg qperintady vgnylyenns nstiaendkn hlsekqdtyl
     1741 snssmsnsys yhsdevynds gylsknklds giepvlknve dqkntsfskv isnvkdanay
     1801 pqtvnedicv eelvtssspc knknaaikls isnsnnfevg ppafriasgk ivcvshetik
     1861 kvkdiftdsf skvikennen kskicqtkim agcyealdds edilhnsldn decsthshkv
     1921 fadiqseeil qhnqnmsgle kvskispcdv sletsdickc sigklhksvs santcgifst
     1981 asgksvqvsd aslqnarqvf seiedstkqv fskvlfksne hsdqltreen tairtpehli
     2041 sqkgfsynvv nssafsgfst asgkqvsile sslhkvkgvl eefdlirteh slhysptsrq
     2101 nvskilprvd krnpehcvns emektcskef klsnnlnveg gssennhsik vspylsqfqq
     2161 dkqqlvlgtk vslvenihvl gkeqaspknv kmeigktetf sdvpvktnie vcstyskdse
     2221 nyfeteavei akafmeddel tdsklpshat hslftcpene emvlsnsrig krrgeplilv
     2281 gepsikrnll nefdriienq ekslkaskst pdgtikdrrl fmhhvslepi tcvpfrttke
     2341 rqeiqnpnft apgqeflsks hlyehltlek sssnlavsgh pfyqvsatrn ekmrhlittg
     2401 rptkvfvppf ktkshfhrve qcvrninlee nrqkqnidgh gsddsknkin dneihqfnkn
     2461 nsnqaaavtf tkceeepldl itslqnardi qdmrikkkqr qrvfpqpgsl ylaktstlpr
     2521 islkaavggq vpsacshkql ytygvskhci kinsknaesf qfhtedyfgk eslwtgkgiq
     2581 ladggwlips ndgkagkeef yralcdtpgv dpklisriwv ynhyrwiiwk laamecafpk
     2641 efanrclspe rvllqlkyry dteidrsrrs aikkimerdd taaktlvlcv sdiislsani
     2701 setssnktss adtqkvaiie ltdgwyavka qldppllavl kngrltvgqk iilhgaelvg
     2761 spdactplea peslmlkisa nstrparwyt klgffpdprp fplplsslfs dggnvgcvdv
     2821 iiqraypiqw mektssglyi frnereeeke aakyveaqqk rlealftkiq eefeeheent
     2881 tkpylpsral trqqvralqd gaelyeavkn aadpaylegy fseeqlraln nhrqmlndkk
     2941 qaqiqleirk amesaeqkeq glsrdvttvw klrivsyskk ekdsvilsiw rpssdlysll
     3001 tegkryriyh latsksksks eraniqlaat kktqyqqlpv sdeilfqiyq preplhfskf
     3061 ldpdfqpscs evdligfvvs vvkktglapf vylsdecynl laikfwidln ediikphmli
     3121 aasnlqwrpe sksglltlfa gdfsvfsasp keghfqetfn kmkntvenid ilcneaenkl
     3181 mhilhandpk wstptkdcts gpytaqiipg tgnkllmssp nceiyyqspl slcmakrksv
     3241 stpvsaqmts ksckgekeid dqknckkrra ldflsrlplp ppvspictfv spaaqkafqp
     3301 prscgtkyet pikkkelnsp qmtpfkkfne isllesnsia deelalintq allsgstgek
     3361 qfisvsestr taptssedyl rlkrrcttsl ikeqessqas teeceknkqd tittkkyi
//

